Home | News | Events | Contact Us | English | 繁體中文 | 日本語
About Us Product & Service Facilities Quality & Compliance For Investors Career
Product & Service 
Home / Product & Service / Antibody Drug Conjugates (ADCs)
Antibody Drug Conjugates (ADCs) 
Formosa Laboratories (Formosa Labs) provides one-stop solution for Antibody-Drug Conjugates (ADCs) manufacturing from antibody production through domestic alliance, to in-house toxin-linker CMC services and antibody bioconjugation for drug substance (DS), and finally through to cytotoxic fill-finish drug product (DP) manufacturing. To demonstrate our capability, Formosa Labs is developing a biosimilar of ado-trastuzumab emtansine (biosimilar Kadcyla), which is available for co-development or out-licensing.

Integrated ADC CMC Service

Ability and Capability
Process Experience
Expertise with more than 10 ADCs conjugated
lysine, cysteine, and proprietary linkage technologies
Post-conjugation ADC purification and characterization:  ÄKTA AVANT 150
mg to g scale

Full Characterization
UV-Vis analysis (Nanodrop 2000)
LC: & HIC / SEC / PLRP (Waters Bio-UPLC, Agilent)
CE-SDS & cIEF assay (Beckman PA800)
ELISA reader (Biotek Synergy H1)
TOF MS (Waters Vion IMS QTOF)




Copyright ©2014 Formosa Laboratories, Inc. All Rights Reserved.